Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
CVRx
CVRX
CVRx
Reimbursement Cuts Will Hinder Prospects Even As Device Uptake Persists
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
10 Aug 25
Updated
10 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$7.00
0.4% overvalued
intrinsic discount
10 Aug
US$7.03
Loading
1Y
-12.9%
7D
-2.9%
Author's Valuation
US$7.0
0.4% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$7.0
0.4% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-54m
113m
2019
2021
2023
2025
2027
2028
Revenue US$112.9m
Earnings US$13.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
17.09%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.08%
Calculation
US$13.94m
Earnings '28
x
28.67x
PE Ratio '28
=
US$399.57m
Market Cap '28
US$399.57m
Market Cap '28
/
45.24m
No. shares '28
=
US$8.83
Share Price '28
US$8.83
Share Price '28
Discounted to 2025 @ 8.06% p.a.
=
US$7.00
Fair Value '25
